Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Macrocarpal C SCHEMBL136282 | 1.00 | PTPN1 (0.68) | PTPN1PLA2R1 | |
| Macrocarpal C SCHEMBL96125 | 1.00 | PTPN1 (0.68) | PTPN1PLA2R1 | |
| Macrocarpal C SCHEMBL23484420 | 1.00 | PTPN1 (0.68) | PTPN1PLA2R1 | |
| Macrocarpal C SCHEMBL4419114 | 1.00 | PTPN1 (0.68) | PTPN1PLA2R1 | |
| SCHEMBL12549609 | 0.92 | PTPN1 (0.61) | PTPN1PLA2R1 | |
| Macrocarpal A SCHEMBL96222 | 0.81 | PTPN1 (1.00) | PTPN1PLA2R1 | |
| Macrocarpal A SCHEMBL13597681 | 0.81 | PTPN1 (1.00) | PTPN1PLA2R1 | |
| Macrocarpal A SCHEMBL13597677 | 0.81 | PTPN1 (1.00) | PTPN1PLA2R1 | |
| Macrocarpal A SCHEMBL4413981 | 0.81 | PTPN1 (1.00) | PTPN1PLA2R1 | |
| Macrocarpal A SCHEMBL23484425 | 0.81 | PTPN1 (1.00) | PTPN1PLA2R1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090324754-A1 | EUCALYPTUS EXTRACT, METHOD OF PREPARATION AND THERAPEUTIC USES THEREOF | PIERRE FABRE MEDICAMENT (FR) | 2009-12-31 | — | — | US | claimed |
| US-20090324754-A1 | EUCALYPTUS EXTRACT, METHOD OF PREPARATION AND THERAPEUTIC USES THEREOF | PIERRE FABRE MEDICAMENT (FR) | 2009-12-31 | — | — | US | disclosed |
| US-20090324754-A1 | EUCALYPTUS EXTRACT, METHOD OF PREPARATION AND THERAPEUTIC USES THEREOF | PIERRE FABRE MEDICAMENT (FR) | 2009-12-31 | — | — | US | disclosed |
| US-20090324754-A1 | EUCALYPTUS EXTRACT, METHOD OF PREPARATION AND THERAPEUTIC USES THEREOF | PIERRE FABRE MEDICAMENT (FR) | 2009-12-31 | — | — | US | disclosed |
| WO-2008017752-A2 | EUCALYPTUS EXTRACT, METHOD OF PREPARATION AND THERAPEUTIC USES THEREOF | PIERRE FABRE MEDICAMENT (FR) | 2008-02-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090324754-A1 | EUCALYPTUS EXTRACT, METHOD OF PREPARATION AND THERAPEUTIC USES THEREOF | NMUR2, NMUR1, NMBR | PTPN1 4527/4885PLA2R1 1686/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.